INNV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INNV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
InnovAge Holding's quarterly buildings and improvements increased from Sep. 2023 ($124.7 Mil) to Dec. 2023 ($132.6 Mil) and increased from Dec. 2023 ($132.6 Mil) to Mar. 2024 ($144.8 Mil).
InnovAge Holding's annual buildings and improvements increased from Jun. 2021 ($104.7 Mil) to Jun. 2022 ($122.1 Mil) and increased from Jun. 2022 ($122.1 Mil) to Jun. 2023 ($124.3 Mil).
The historical data trend for InnovAge Holding's Buildings And Improvements can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InnovAge Holding Annual Data | |||||||||||
Trend | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | ||||||
Buildings And Improvements | 74.48 | 79.51 | 104.72 | 122.08 | 124.26 |
InnovAge Holding Quarterly Data | |||||||||||||||||||
Jun19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Buildings And Improvements | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
124.23 | 124.26 | 124.70 | 132.55 | 144.85 |
Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.
Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.
Teresa Sparks | director | 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215 |
Nicole Damato | officer: CHIEF LEGAL OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Benjamin C Adams | officer: CHIEF FINANCIAL OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Patricia Fontneau | director | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Christine Bent | officer: CHIEF OPERATIONS OFFICER | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Thomas Scully | director | 320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022 |
Richard Feifer | officer: CHIEF MEDICAL OFFICER | C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348 |
James G Carlson | director | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Patrick T Blair | officer: PRESIDENT | 8950 E. LOWRY BOULEVARD, DENVER CO 80230 |
Caroline Dechert | director | 580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104 |
Pavithra Mahesh | director | 601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022 |
Maureen Hewitt | director, officer: CEO, President and Director | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Maria Lozzano | officer: CORPORATE COO | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Robin Doerr | officer: CHIEF SALES AND MKTG. OFFICER | 8950 E. LOWRY BLVD., DENVER CO 80230 |
Melissa Welch | officer: CHIEF MEDICAL OFFICER | 8950 E. LOWRY BLVD., DENVER CO 80230 |
From GuruFocus
By Marketwired • 10-02-2023
By Value_Insider Value_Insider • 11-22-2022
By PRNewswire PRNewswire • 06-03-2022
By Stock market mentor Stock market mentor • 01-24-2023
By Marketwired • 09-12-2023
By Ds*** Ds*** • 09-02-2022
By PRNewswire PRNewswire • 06-13-2022
By sperokesalga sperokesalga • 06-05-2023
By GuruFocusNews GuruFocusNews • 07-10-2022
By PRNewswire PRNewswire • 07-03-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.